Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells

Cancer Research

Volumn 66, Issue 22, 2006, Pages 10691-10700

  Wen, Victoria W ^a   Wu, Kaida ^b   Baksh, Sheik ^b   Hinshelwood, Rebecca A ^c   Lock, Richard B ^a   Clark, Susan J ^c   Moore, Malcolm A S ^b   MacKenzie, Karen L ^a  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P16INK4A; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CELL CLONE; CELL CULTURE; CELL IMMORTALIZATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DICENTRIC CHROMOSOME; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KARYOTYPING; PRIORITY JOURNAL; TELOMERE;

BONE MARROW CELLS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; ENDOTHELIAL CELLS; GENE SILENCING; GENES, P53; HUMANS; KARYOTYPING; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TELOMERASE; TELOMERE; TRANSDUCTION, GENETIC;

EID: 33845294825     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0979     Document Type: Article

References (50)

1. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995;92:11190-4.
2. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988;85:6622-26.
3. Griffith JD, Comeau L, Rosenfleld S, et al. Mammalian telomeres end in a large duplex loop. Cell 1999;97:503-14.
4. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-29.
5. Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-5.
6. Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 1999;144:589-601.
7. Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001;28:155-9.
8. O'Hagan RC, Chang S, Maser RS, et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2002;2:149-55.
9. O'Sullivan JN, Bronner MP, Brentnall TA, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280-4.
10. Chin K, de Solorzano CO, Knowles D, et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004;36:984-8.
11. Bell CD. Endothelial cell tumors. Microsc Res Tech 2003;60:165-70.
12. Schuborg C, Mertens F, Rydholm A, et al. Cytogenetic analysis of four angiosarcomas from deep and superficial soft tissue. Cancer Genet Cytogenet 1998;100:52-6.
13. Wong KF, So CC, Wong N, et al. Sinonasal angiosarcoma with marrow involvement at presentation mimicking malignant lymphoma: cytogenetic analysis using multiple techniques. Cancer Genet Cytogenet 2001;129:64-8.
14. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999;283:1321-5.
15. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-8.
16. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 2004;14:501-13.
17. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999;97:527-38.
18. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76.
19. Jacobs JJ, de Lange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr Biol 2004;14:2302-8.
20. Gimbrone MA, Jr., Fareed GC. Transformation of cultured human vascular endothelium by SV40 DNA. Cell 1976;9:685-93.
21. Fontijn R, Hop C, Brinkman H-J, et al. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp Cell Res 1995;216:199-207.
22. Girardi AJ, Jensen FC, Koprowski H. SV40-induced transformation of human diploid cells: crisis and recovery. J Cell Comp Physiol 1965;65:69-84.
23. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-4.
24. Bodnar AG, Oullette M, Froklis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
25. Kiyono T, Foster SA, Koop JI, et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-8.
26. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits lifespan become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-47.
27. Tsutsui T, Kumakura S, Yamamoto A, et al. Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis 2002;23:2111-7.
28. Milyavsky M, Shats I, Erez N, et al. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res 2003;63:7147-57.
29. Noble JR, Zhong ZH, Neumann AA, et al. Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts. Oncogene 2004;23:3116-21.
30. Taylor LM, James A, Schuller CE, et al. Inactivation of p16INK4a, with retention of pRB and p53/p21cip1 function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization. J Biol Chem 2004;279:43634-45.
31. Yang J, Chang E, Cherry AM, et al. Human endothelial cell lifespan extension by telomerase expression. J Biol Chem 1999;274:26141-8.
32. MacKenzie KL, Franco S, Naiyer AJ, et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene 2002;21:4200-11.
33. O'Hare MJ, Bond J, Clarke C, et al. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A 2001;98:646-51.
34. Dai C, Krantz SB. Increased expression of the INK4a/ ARF locus in polycythemia vera. Blood 2001;97:3424-32.
35. Huschtscha LI, Noble JR, Neumann AA, et al. Loss of P16(INK4) expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 1998;58:3508-12.
36. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-7.
37. Ouellette MM, Liao M, Herbet BS, et al. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem 2000;275:10072-6.
38. Liu Y, Kha H, Ungrin M, Robinson MO, Harrington L. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci U S A 2002;99:3597-602.
39. Gisselsson D, Pettersson L, Hoglund M, et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A 2000;97:5357-62.
40. Romanov SR, Kozakiewicz BK, Holst CR, et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001;409:633-7.
41. Soler D, Genesca A, Arnedo G, Egozcue J, Tusell L. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells. Genes Chromosomes Cancer 2005;44:339-50.
42. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science 1996;271:1744-7.
43. der-Sarkissian H, Bacchetti S, Cazes L, Londono-Vallejo JA. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene 2004;23:1221-8.
44. Johnson TE, Umbenhauer DR, Hill R, et al. Karyotypic and phenotypic changes during in vitro aging of human endothelial cells. J Cell Physiol 1992;150:17-27.
45. Zhang L, Aviv H, Gardner JP, et al. Loss of chromosome 13 in cultured human vascular endothelial cells. Exp Cell Res 2000;260:357-64.
46. Dessen P, Knuutila S, Huret JL. Chromosome 17. Atlas of Genetics and Cytogenetics in Oncology and Haematology [homepage on the Internet]. 2002 [updated 2006 Aug 28; cited 2006 Aug 28] Available from: http:// AtlasGeneticsOncology.org/Indexbychromosom/idxa_17.html.
47. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999;21:111-4.
48. MacKenzie KL, Franco S, May C, Sadelain M, Moore MAS. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp Cell Res 2000;259:336-50.
49. Kurz DJ, Decary S, Hong Y, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 2004;117:2417-26.
50. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001;107:67-77.